The High (125 ng/ml) Control does not meet specification - it has been confirmed to produce values below 100 ng/mL when run on validated clinical chemistry analyzers, which is below the 100 ng/mL cutoff of the EDDP Specific Urine Enzyme Immunoassay with which this control is utilized.
Source facts
Action
On November 28, 2017, the firm sent their customer notifications of the recall stating the following:
CUSTOMER REQUIRED ACTION
1. If you have product in your possession:
" Immediately discontinue use and/or sale of affected product lot and place in quarantine.
" Complete the enclose Customer Verification Form, within 10 days, indicating the quantity of product you have discarded or will return to lmmunalysis.
" FAX completed Customer Verification Form to 909-482-0850 or scan and email to rtimbang@immunalysis.com
" Upon receipt of your Customer Verification Form, we will initiate shipment of replacement product in the quantity indicated on the form and, if applicable, will contact you to arrange product return.
" Return product as directed.
2. If you have no remaining product in your possession:
" Complete the enclosed Customer Verification Form, within 10 days, indicating "We do not have any affected product - it has been consumed".
" FAX completed Customer Verification Form to 909-482-0850 or scan and email to rtimbang@immunalysis.com
3. Share this information with your staff and retain this notification as part of your records.
Please complete this form and return within 10 days even if you do not have any
remaining product. Send form to lmmunalysis at Fax 909-482-0850 or by e-mail to rtimbang@immunalysis.com
For further questions, please call (207) 730-5738.
Initiated
2017-11-28
Root cause
Under Investigation by firm
Terminated
2021-01-29
Distribution
US Distribution to the states of : CA, CO, CT, FL, LA, MD, NC, NJ, OH, OK, TN, TX, WI, and WV
Recall number
Z-2140-2018
Recall status
Terminated
CDRH record ID
164551
FDA record created
2018-06-08
Recall event number
80096
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.